Atlas Trials

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

Clinical trial NCT01369563 · COMPLETED

Trial details

NCT number
NCT01369563
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Perennial RhinitisSeasonal Rhinitis
Start date
2011-08-01
Primary completion
2012-05-01
Enrollment
1630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.